TY - JOUR AU - González Sánchez, Diego Andrés AU - Ayala Ramírez, Daniela AU - Aguirre, Daniela AU - Mercado Juri, Álvaro AU - Rodelo Ceballos, Joaquín AU - Ustariz, José Manuel PY - 2016/11/18 Y2 - 2024/03/28 TI - Clinical results of a kidney protection program in patients with chronic kidney disease stage 5 at medellín, colombia. Preliminary Report JF - Revista Colombiana de Nefrología JA - Rev. Colomb. Nefrol. VL - 3 IS - 2 SE - Original Article DO - 10.22265/acnef.3.2.242 UR - https://revistanefrologia.org/index.php/rcn/article/view/242 SP - 99-106 AB - <p><strong>Introduction:</strong> Chronic kidney disease remains a major cause of morbidity and mortality in our environment. A proper medical intervention of risk factors slow disease progression to dialysis. The usefulness of renal protection programs in our country has not been evaluated.</p><p><strong>Objective:</strong> To describe the clinical and medical results obtained in patients with chronic kidney disease stage 5 belonging to renal protection program.</p><p><strong>Materials and Methods:</strong> A total of 4727 patients belong to renal protection program at the Medellin General Hospital-Savia Salud started in November 2013 and followed up until December 31, 2015. Those patients with GFRe &lt; 15 cc/min by Cockcroft-Gault were included taking into account the guidelines and policies of high cost in Colombia. We excluded patients with a history of renal transplantation.</p><p><strong>Results:</strong> A total of 112 patients were included in the analysis, with an average age of 71.8 years and an average follow-up of 343.2 days. Diabetic nephropathy was the leading cause of chronic kidney disease with 36.6 %. The mortality rate was 6.25% (7 deaths), median dialysis-free days was 694 days IQR (199 -&gt; 694) and average reduction in GFRe by MDRD was -2.88 ml/min/year.</p><p><strong>Conclusions:</strong> Renal protection programs are a useful tool in the management of patients with advanced chronic kidney disease and help slow the progression to dialysis.</p> ER -